论文部分内容阅读
目的观察双黄连颗粒佐治小儿支原体肺炎的临床效果。方法将200例支原体肺炎患儿随机分为观察组和对照组各100例。对照组给予阿奇霉素治疗。观察组在对照组基础上加用双黄连颗粒治疗。对比2组临床疗效,体温恢复时间,咳嗽消失时间,胸部X线片恢复正常时间,抗体转阴时间,住院时间和并发症发生情况。结果观察组总有效率高于对照组,体温恢复时间、咳嗽消失时间、胸部X线片恢复正常时间、抗体转阴时间和住院时间均短于对照组,并发症发生率低于对照组,差异均有统计学意义(P<0.05)。结论双黄连颗粒佐治小儿支原体肺炎效果较好,可明显改善患者的临床症状,缩短患者住院时间,节约医疗费用,值得临床推广应用。
Objective To observe the clinical effect of shuanghuanglian granules in treating children with mycoplasma pneumonia. Methods 200 children with mycoplasma pneumonia were randomly divided into observation group and control group with 100 cases each. The control group was treated with azithromycin. The observation group was added Shuanghuanglian granules on the basis of the control group. The clinical efficacy, body temperature recovery time, cough disappearance time, chest X-ray film recovery time, antibody negative time, hospital stay and complications were compared between the two groups. Results The total effective rate of the observation group was higher than that of the control group. The recovery time of body temperature, the time of cough disappearance, the recovery time of the chest X-ray film, the time of antibody negative conversion and hospital stay were shorter than those of the control group. The incidence of complications was lower than that of the control group All were statistically significant (P <0.05). Conclusion Shuanghuanglian particles adjuvant treatment of children with mycoplasma pneumonia better, can significantly improve the patient’s clinical symptoms, shorten hospital stay, save medical costs, it is worth promoting the clinical application.